Clinical Trials Logo

Clinical Trial Summary

This is a prospective evaluation of the clinical utility of the new cholangioscopy platform SpyGlass DS. The aims of this study are to prospectively document the clinical utility and technical aspects of ERCP with cholangioscopy and/or pancreatoscopy in the diagnosis and management of pancreata-biliary disorders.


Clinical Trial Description

Cholangioscopy allows for direct visualization of the bile and pancreatic duct. In 2006, the SpyGlass Direct Visualization System for per-oral cholangiopancreatoscopy was introduced and since then has been shown to provide incremental diagnostic and therapeutic benefits. The main limitations of the original SpyGlass platform are fiberoptic visualization system, limited tip angulation, square cut Spy scope tip, and complex multicomponent setup. A new generation cholangioscopy platform, SpyGlass DS is currently in clinical use. The new system addresses many of the shortcomings of old platform including digital optics, improved tip angulation, tapered tip and simplified set up. It is unclear at this time wether this technical improvement will translate into better outcomes. Therefore, the investigators want to study the clinical utility of SpyGlass DS by prospectively collecting data on the clinical outcomes of patients undergoing cholangioscopy with Spyglass DS as part of their routine medical care. ;


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT02524418
Study type Interventional
Source University of Florida
Contact Peter V Draganov, MD
Phone 352-273-9474
Email dragapv@medicine.ufl.edu
Status Recruiting
Phase N/A
Start date August 2015
Completion date June 2020

See also
  Status Clinical Trial Phase
Completed NCT00124202 - Effect of a Fatty Meal on Endoscopic Retrograde Cholangiopancreatography (ERCP) Phase 1/Phase 2
Completed NCT00201305 - Gemcitabine Plus High-Dose 5-Fu/Leucovorin in the Treatment of Advanced or Metastatic Carcinoma of the Biliary Tract Phase 2
Withdrawn NCT02118493 - Endo-biliary Laser Excision of Biliary Stenoses N/A